Why People Consider Microdosing GLP-1 Medications Several factors drive interest in microdosing these powerful medications
Liraglutide (a daily injection) resulted in an average 4-5% weight loss in 24 trials (9 937 participants), still outperforming placebo
All the aforementioned results have suggested that GLP-1RAs are safe and beneficial for the treatment of pancreatitis and pancreatic cancer
Prather says these medications impact on weight loss and, thereby, reduced systemic inflammation could become an important tool for treating patients at high risk due to poor type 2 diabetes control and obesity before surgeryor even helping them to avoid surgery in the first place
No waiting rooms, no commute, and no insurance required
A., Nicolas, S., & Shivkumar, A